Before we begin, I'd like to remind everyone that during this call, certain statements made are forward-looking statements within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995,

This immediate, non-dilutive funding is being advanced in addition to the $54.9 million of funding committed to date as part of the Company’s current contract with BARDA (the “BARDA Contract”) valued up to $150.

Spectral AI received $31.7 million of funding from the Biomedical Advanced Research and Development Authority to speed the development of its DeepView System, an artificial-intelligence tool for burn wound imaging.

Spectral AI, Inc. (NASDAQ:MDAI) Q4 2025 Earnings Call Transcript March 24, 2026 Spectral AI, Inc. beats earnings expectations. Reported EPS is $0.02, expectations were $-0.12667. Operator: Good afternoon,

Overview Full Year Research & Development Revenue of $19.7 Million; Q4 2025 Revenue of $3.8 MillionCash Rose to $15.4 Million at December 31, 2025 DALLAS, March 24, 2026 (GLOBE NEWSWIRE) -- Spectral

We feel now is a pretty good time to analyse Spectral Medical Inc.'s ( TSE:EDT ) business as it appears the company

Spectral AI, a leading developer of innovative diagnostic tools, has released its 2025 fourth quarter and full year financial results, showcasing remarkable progress towards commercializing its DeepView system for burn indication.